opaganib
Generic: Opaganib
opaganib: 1 clinical trial tracked.
opaganib evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about opaganib, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia: a Randomized, Double-blind, Placebo-Controlled Phase 2/3 Study, in Adult Subjects Hospitalized With Severe SARS-CoV-2 Positive Pneumonia
Primary endpoint: Supplemental Oxygen Requirement
InterventionalRandomizedquadruple475 enrolledStarted 2020-08Completion 2021-0750 sites · Brazil, Colombia, Israel, Italy…RedHill Biopharma Limited